 Connection
Todd Bull to Scleroderma, Systemic
This is a "connection" page, showing publications Todd Bull has written about Scleroderma, Systemic.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.705 |
|
|
|
-
Lee MH, Bull TM. The role of pulmonary arterial hypertension-targeted therapy in systemic sclerosis. F1000Res. 2019; 8.
Score: 0.612
-
Risbano MG, Meadows CA, Coldren CD, Jenkins TJ, Edwards MG, Collier D, Huber W, Mack DG, Fontenot AP, Geraci MW, Bull TM. Altered immune phenotype in peripheral blood cells of patients with scleroderma-associated pulmonary hypertension. Clin Transl Sci. 2010 Oct; 3(5):210-8.
Score: 0.323
-
Meadows CA, Risbano MG, Zhang L, Geraci MW, Tuder RM, Collier DH, Bull TM. Increased expression of growth differentiation factor-15 in systemic sclerosis-associated pulmonary arterial hypertension. Chest. 2011 May; 139(5):994-1002.
Score: 0.322
-
Bull TM. Screening and therapy of pulmonary hypertension in systemic sclerosis. Curr Opin Rheumatol. 2007 Nov; 19(6):598-603.
Score: 0.264
-
Solomon JJ, Olson AL, Fischer A, Bull T, Brown KK, Raghu G. Scleroderma lung disease. Eur Respir Rev. 2013 Mar 01; 22(127):6-19.
Score: 0.095
-
Fischer A, Bull TM, Steen VD. Practical approach to screening for scleroderma-associated pulmonary arterial hypertension. Arthritis Care Res (Hoboken). 2012 Mar; 64(3):303-10.
Score: 0.089
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|